The change of some cytokine levels during immune-checkpoint inhibitor treatment in R/M head and neck cancer patients

被引：0
|
作者：
Komatsu, Nobukazu [1 ,2 ]
Ono, Takeharu [3 ]
Yokomizo, Kanako [2 ]
Yamada, Akira [2 ]
Umeno, Hirohito [3 ]
机构：
[1] Kurume Univ, Dept Immunol, Sch Med, Kurume, Japan
[2] Kurume Univ, Res Ctr Innovat Canc Therapy, Kurume, Japan
[3] Kurume Univ, Sch Med, Dept Otolaryngol, Kurume, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2201
引用
收藏
页码：1409 / 1409
页数：1
相关论文
共 50 条
  • [41] Immune Checkpoint Inhibitors Serve as the First-Line Treatment for Advanced Head and Neck Cancer
    Huang, Yan
    Zhou, Hong
    Zhao, Guangyong
    Wang, Meihua
    Luo, Judong
    Liu, Jun
    LARYNGOSCOPE, 2024, 134 (02): : 749 - 761
  • [42] Incidence of severe adverse events in cancer patients after treatment with immune-checkpoint inhibitors during the COVID- 19 pandemic
    Sakiko Kimura
    Hiroo Katsuya
    Chiho Nakashima
    Naoko Sueoka-Aragane
    Koji Hayashida
    Kazumi Sasaki
    Rintaro Sogawa
    Tatsuya Furuno
    Moriyasu Yamauchi
    Yoichiro Sugiyama
    Hirokazu Noshiro
    Motohiro Esaki
    Mitsuru Noguchi
    Hirokazu Takahashi
    Keizo Anzai
    Masatoshi Yokoyama
    Kazunari Sugita
    Yoshio Yamashita
    Atsushi Kawaguchi
    Shinya Kimura
    Chisato Shimanoe
    BMC Immunology, 26 (1)
  • [43] Investigating the combination of radiation and subsequent immune checkpoint inhibitor treatment in head and neck squamous cell carcinoma models
    Lind, Hanne
    Strait, Alexander
    Hall, Spencer
    Goon, Jack B.
    Aleman, John D.
    Chen, Samantha
    Owens, Philip
    Wang, Jing H.
    Young, Christian
    Wang, Xiao-Jing
    CANCER RESEARCH, 2024, 84 (06)
  • [44] Clinical significance of KL-6 in immune-checkpoint inhibitor treatment for non-small cell lung cancer
    Nakahama, Kenji
    Izumi, Motohiro
    Yoshimoto, Naoki
    Fukui, Mitsuru
    Sugimoto, Akira
    Nagamine, Hiroaki
    Ogawa, Koichi
    Sawa, Kenji
    Tani, Yoko
    Kaneda, Hiroyasu
    Mitsuoka, Shigeki
    Watanabe, Tetsuya
    Asai, Kazuhisa
    Kawaguchi, Tomoya
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2023, 92 (05) : 381 - 390
  • [45] Treatment sequence of cetuximab and immune checkpoint inhibitor in head and neck squamous cell carcinoma differentially affects outcomes
    Park, Jong Chul
    Durbeck, Julia
    Clark, John R.
    Faden, Daniel L.
    ORAL ONCOLOGY, 2020, 111
  • [46] Feasibility of Near-infrared Photoimmunotherapy Combined With Immune Checkpoint Inhibitor Therapy in Unresectable Head and Neck Cancer
    Hirakawa, Hitoshi
    Ikegami, Taro
    Kinjyo, Hidetoshi
    Hayashi, Yoshikazu
    Agena, Shinya
    Higa, Teruyuki
    Kondo, Shunsuke
    Toyama, Masatomo
    Maeda, Hiroyuki
    Suzuki, Mikio
    ANTICANCER RESEARCH, 2024, 44 (09) : 3907 - 3912
  • [47] Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for treatment of recurrent or metastatic head and neck squamous cell carcinoma: a systematic review and network meta-analysis
    Jin, Zhe
    Zhang, Bin
    Zhang, Lu
    Huang, Wenhui
    Mo, Xiaokai
    Chen, Qiuyin
    Wang, Fei
    Chen, Zhuozhi
    Li, Minmin
    Zhang, Shuixing
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [48] Association of Immune Checkpoint Inhibitor Treatment and Emphysema Progression in Patients With Urothelial Cancer
    Zo, S.
    Kang, D.
    Oh, Y.
    Seo, S.
    Jeong, B.
    Park, S.
    Cho, J.
    Lee, H.
    Park, H.
    Shin, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [49] Clinical significance of KL-6 in immune-checkpoint inhibitor treatment for non-small cell lung cancer
    Kenji Nakahama
    Motohiro Izumi
    Naoki Yoshimoto
    Mitsuru Fukui
    Akira Sugimoto
    Hiroaki Nagamine
    Koichi Ogawa
    Kenji Sawa
    Yoko Tani
    Hiroyasu Kaneda
    Shigeki Mitsuoka
    Tetsuya Watanabe
    Kazuhisa Asai
    Tomoya Kawaguchi
    Cancer Chemotherapy and Pharmacology, 2023, 92 : 381 - 390
  • [50] CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES OF IMMUNE CHECKPOINT INHIBITOR GASTRITIS IN PATIENTS WITH CANCER
    Haryal, Aneesha
    Baskaran, Vinitha
    Srivoleti, Padmavathi
    Sack, Jordan S.
    Grover, Shilpa
    GASTROENTEROLOGY, 2022, 162 (07) : S905 - S905
12345